Search Tag: Fresenius Medical Care
2024 23 Dec
Ranking puts Fresenius Medical Care among the best-in-class sustainability performers in the world and Europe The company recorded progress towards its sustainability targets Sustainability is one of the essential drivers for future Fresenius Medical Care (FME), the world’s leading provider of products and services for individuals with...Read more
2024 19 Nov
Strategic Relationship: Agreement expands access to ECMO solutions for hospitals, health systems and patients in the U.S. nationwide. Wide Reach: 4,350+ Premier member hospitals and health systems in the U.S. can leverage pre-negotiated terms and pricing on the Novalung System for ECMO. Commitment to Quality Care: Reinforces company’s...Read more
2024 18 Nov
Fresenius Medical Care’s application of the Anemia Control Model recognized as one of only six projects chosen from over 300 submissions across all healthcare segments. This selection highlights Fresenius Medical Care’s commitment to improving kidney care and outcomes through innovative analytics and clinical expertise. Anemia Control...Read more
2024 01 Nov
Fresenius Medical Care (FME ), the world's leading provider of products and services for individuals with renal diseases, is pleased to share that our company and our Management Board Chair and CEO, Helen Giza, was named by The Women’s Edge in partnership with The Boston Globe for the first time to its annual Top 100 Women-Led Businesses...Read more
2024 21 Oct
A dedicated session will highlight new advancements in hemodiafiltration therapy showcasing its potential to improve patient outcomes through enhanced toxin removal in dialysis treatments. Company-wide researchers and clinical experts share insights from large global databases, revealing crucial trends in kidney failure etiology, cardiovascular...Read more
2024 15 Oct
Fresenius Medical Care (FME) , the world’s leading provider of products and services for individuals with renal diseases, has reopened all its dialysis clinics in the regions affected by Hurricane Milton since Monday, October 14, and Hurricane Helene on Tuesday, October 1. Because of our ongoing preparedness efforts, all clinics are back...Read more
2024 15 Oct
Xenios 2.0 is Fresenius Medical Care’s MDR-approved system for ECLS treatments applicable for all patients, from neonates to adults. The system provides cutting-edge technical safety features and intelligent troubleshooting for physicians and caregivers. Xenios 2.0 was developed according to the principles of safety, simplicity, and connectivity....Read more
2024 10 Oct
Fresenius Medical Care (FME), the world’s leading provider of products and services for individuals with renal diseases, is supporting customers, patients, staff, and clinics to ensure there is no disruption in current or potential Fresenius Kidney Care Home patients receiving their peritoneal dialysis care. FME has a plan in place to monitor and...Read more
2024 23 Sep
Fresenius Medical Care (FME) achieves top results in this year's “2024 Developed Europe Executive Team Survey” by the market research company Extel in six categories. The Extel ranking is regarded as one of the most authoritative surveys in the financial sector and evaluates companies and their managers based on feedback from institutional investors...Read more
2024 22 Mar
Fresenius Medical Care delivers on commitments during a year of fundamental transformation Progress towards sustainability goals in key areas: patient satisfaction, diversity in management, climate target roadmap Fresenius Medical Care (FME), the world’s leading provider of products and services for individuals with renal diseases,...Read more
2024 22 Mar
Fresenius Medical Care delivers on commitments during a year of fundamental transformation Progress towards sustainability goals in key areas: patient satisfaction, diversity in management, climate target roadmap Fresenius Medical Care (FME), the world’s leading provider of products and services for individuals with renal diseases,...Read more
2024 19 Mar
For the first time, Fresenius Medical Care develops and utilizes “Augmented Reality” (AR) to train medical staff in Intensive Care Units (ICUs) The new training application for ICU staff combines digital learning elements with real-life training on the Fresenius Medical Care Continuous Kidney Replacement Therapy system This learning experience...Read more
2024 19 Mar
For the first time, Fresenius Medical Care develops and utilizes “Augmented Reality” (AR) to train medical staff in Intensive Care Units (ICUs) The new training application for ICU staff combines digital learning elements with real-life training on the Fresenius Medical Care Continuous Kidney Replacement Therapy system This learning experience...Read more
2024 05 Mar
Divestment of assets includes four separate country transactions to DaVita Inc. for USD 300 million Transactions further reduce the Company`s clinic footprint in Latin America, following the exit from Argentina at the end of 2023 Expected to close throughout 2024 Proceeds to be used to reduce debt Fresenius...Read more
2024 20 Feb
Revenue growth of 5% in 2023 driven by favorable business development Operating income 1 growth of 15% exceeding top end of outlook range, due to business growth, FME25 savings ahead of plan and contributions from the Tricare settlement Successful execution on turnaround plan resulting in significant labor productivity improvements in...Read more
2024 08 Feb
Fresenius Medical Care (FME) receives U.S. Food and Drug Administration (FDA) 510(k) clearance of the company’s 5008X Hemodialysis System. This will enable Fresenius Medical Care to offer the industry-leading, high-volume hemodiafiltration (Hv-HDF) dialysis therapy – already widely used in Europe – for people living with kidney diseases...Read more
2024 01 Jan
Raymond van den Busken, an accomplished professional with a diverse background in the medical industry, is set to assume the role of Managing Director of Commercial Operations at Fresenius Medical Care for the Benelux region. With an extensive track record in leading various divisions and managing critical portfolios, van den Busken brings valuable...Read more
2023 10 Jul
Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases has appointed Martin Fischer (46) as Chief Financial Officer as of October 1, 2023. He will succeed Helen Giza who was appointed as Chief Executive Officer and Chair of the Management Board in December 2022 and continues to serve as acting...Read more
2022 25 Oct
VR app for extracorporeal heart and lung support at ESCIM LIVES 2022 Fresenius Medical Care’s heart & lung division Xenios AG presents its virtual reality application at ESCIM LIVES congress in Paris. Visitors can discover a fictitious ECMO case and interactive hands-on experiences. Fresenius Medical Care’s heart & lung division Xenios...Read more
2022 03 May
Dr. Carla Kriwet (51) will become the new CEO of Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, on January 1, 2023. The Supervisory Board of Fresenius Medical Care Management AG unanimously appointed her to succeed Rice Powell (66), who in accordance with the company’s age limit for...Read more
2021 07 Jan
Fresenius Medical Care, the world’s leading provider of products and services for people with chronic kidney failure, will offer the Seraph 100 Microbind Affinity Blood Filter from ExThera Medical Corporation in several European countries as of now. Both companies have signed a co-marketing and distribution agreement, effective in January 2021 and...Read more
2020 30 Apr
As the coronavirus spreads and infections with COVID-19 further increase throughout Europe, ECMO therapy turns out to be a necessary option for patients with severe courses. Xenios AG , a subsidiary of Fresenius Medical Care, provides ECMO consoles that can be used for the treatment of patients who develop severe pneumonia and ARDS with lung...Read more
2020 23 Apr
RenalSense has started commercial sales of its Clarity RMSTM system in Europe in conjunction with its distribution partner Fresenius Medical Care (Bad Homburg). The Clarity RMS received CE Mark approval in August 2019. AKI occurs in over 55% of ICU patients, and is often associated with a high risk of chronic kidney disease, as well as increased...Read more
2019 08 May
The Xenios AG, pioneer in extracorporeal heart and lung support, has restructured its website. Xenios AG has been part of the Fresenius Medical Care Group since 2016 and the new design also serves to bring the company visually in line with the brand image of its parent. www.xenios-ag.com With this newly structured website, the...Read more